IsoRay, Inc.
(NYSE Amex Equities : ISR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -2.22%528.601.0%$696.25m
DHRDanaher Corp. -2.79%270.290.7%$677.46m
ABTAbbott Laboratories 0.02%102.470.8%$573.28m
MDTMedtronic Plc -1.98%82.750.6%$541.63m
ISRGIntuitive Surgical, Inc. -4.02%189.750.8%$347.51m
SYKStryker Corp. -1.41%208.431.3%$304.45m
BSXBoston Scientific Corp. -1.89%39.881.0%$259.91m
BDXBecton, Dickinson & Co. -2.08%223.641.0%$259.03m
DXCMDexCom, Inc. 7.62%102.471.9%$247.26m
EWEdwards Lifesciences Corp. -2.42%84.390.4%$237.34m
ALGNAlign Technology, Inc. -3.50%214.586.4%$203.74m
AAgilent Technologies, Inc. -2.93%128.311.7%$190.91m
BAXBaxter International, Inc. -1.24%55.551.8%$167.81m
STESTERIS Plc (Ireland) -0.99%171.043.1%$146.72m
MTDMettler-Toledo International, Inc. -3.06%1166.365.9%$135.46m

Company Profile

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.